|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 172.85 CHF | -0.89% |
|
-3.73% | +6.63% |
| 09/07 | RBC Expects Slowdown in Galderma's Q2 Sales Growth; Price Target, Estimates Revised | MT |
| 08/07 | Swiss Market Index Slips Back into Red; Barry Callebaut Shares Down | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.89% | -3.73% | +2.55% | +8.17% | +6.63% | +37.95% | - | - | - | 5.03TCr | |
| +0.36% | -0.38% | -0.60% | +6.16% | +3.93% | +1.91% | -6.86% | +2.47% | +118.84% | 23TCr | |
| +2.60% | -1.96% | -8.65% | -4.58% | +62.34% | +125.50% | - | - | - | 934.96Cr | |
| +0.20% | -0.51% | +7.37% | -18.18% | +20.94% | +5.64% | -56.89% | -65.17% | -6.10% | 681.5Cr | |
| +5.85% | +1.57% | +10.11% | -6.67% | +3.01% | -7.30% | +24.60% | -48.60% | -70.79% | 506.88Cr | |
| +1.31% | +0.43% | +26.48% | +17.84% | +0.93% | -30.21% | -32.37% | +190.61% | - | 452.34Cr | |
| +0.73% | -0.09% | +19.10% | +28.26% | +40.61% | -12.05% | -11.58% | +66.08% | +325.54% | 382Cr | |
| +1.25% | -3.66% | -8.96% | -5.53% | -15.71% | -30.22% | -46.17% | -35.02% | - | 333.89Cr | |
| +0.63% | +0.02% | +2.37% | +12.91% | +7.00% | -22.28% | -47.92% | -29.82% | +191.88% | 258.21Cr | |
| +0.46% | -4.45% | -2.00% | +13.70% | +9.67% | +0.85% | - | - | - | 199.28Cr | |
| +5.16% | -2.61% | +10.34% | +3.23% | -27.27% | -55.73% | -82.78% | -74.83% | -91.73% | 197.22Cr | |
| +2.42% | -1.61% | -3.76% | -15.60% | -19.97% | -28.43% | -65.49% | -87.90% | - | 196.96Cr | |
| +1.07% | -6.79% | +5.74% | +24.38% | +59.62% | +84.60% | +387.10% | +285.40% | - | 183.96Cr | |
| -0.23% | -3.24% | +0.27% | -10.53% | -0.42% | -10.97% | -61.74% | -69.49% | -41.11% | 183.29Cr | |
| -3.08% | +1.34% | +38.28% | +19.06% | -10.86% | -27.66% | +1.97% | -35.66% | - | 174.76Cr | |
| +3.60% | -9.59% | +23.69% | +34.98% | +71.50% | +0.57% | +132.28% | +95.77% | +6.61% | 167.42Cr | |
| -1.00% | -8.17% | -6.21% | +10.56% | +34.17% | -13.96% | - | - | - | 164.34Cr | |
| +3.40% | +1.25% | -1.02% | -12.43% | -9.50% | -26.14% | -6.54% | -60.03% | -84.76% | 132.98Cr | |
| -0.46% | -5.86% | -22.04% | -46.99% | -64.23% | -68.47% | +1.92% | - | - | 132.24Cr | |
| -0.46% | +2.61% | +4.10% | -7.50% | +5.95% | -29.65% | +92.96% | +30.83% | +7.27% | 130.49Cr | |
| Average | +1.15% | -2.76% | +4.86% | +2.56% | +8.92% | -5.30% | +13.90% | +10.98% | +35.56% | 1.68TCr | |
| Weighted average by Cap. | +0.38% | -1.10% | +0.80% | +5.62% | +6.57% | +8.67% | -6.14% | +3.46% | +110.55% |
- Stock Market
- Stocks
- GALD Stock
- Sector Galderma Group AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition